Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

顺尔宁 - NMPA Drug Approval Details

Approvals/NMPA/Montelukast Sodium Tablets

Approved

化学药品

Montelukast Sodium Tablets

Organon NV🇨🇳 National Medical Products Administration

Approval Date: Nov 4, 2022
Approval ID: ef5d7e14164ec108
Company: Organon NV
Type: 化学药品

Approval Details

Approval Id: ef5d7e14164ec108
Approval Number: 国药准字HJ20181188
Generic Name: 孟鲁司特钠片
Generic Name En: Montelukast Sodium Tablets
Trade Name: 顺尔宁
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 10mg（按C₃₅H₃₆ClNO₃S计）
Reg Date: 2022-11-04
Expired Date: 2027-11-03
Company Name: Organon NV
Production Company Name: ORGANON PHARMA (UK) LIMITED
Company Detail Path: /organization/organon-nv
Production Company Detail Path: /organization/organon-pharma-uk-limited

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 4, 2022

Approval ID

ef5d7e14164ec108

Type

化学药品

Back to NMPA Approvals